Skip to main content
. 2022 Jun 3;48:82. doi: 10.1186/s13052-022-01274-x

Table 1.

Reports from 1996 to 2007

Main features Østergaard [2] Østergaard [9] Ramelli [10] Lance [11] Weiss [12] Carlow [13] Carlow [13]
Age at onset 18 mo 7 mo 20 mo 9 mo 24 mo 18 mo 18 mo
Current age 8 yr 19 yr 8 yr 16 yr 7 yr - -
Sex F F F F M F F
CN involved (side) III (L) III(L) III (R) III (L) III (L) - -
Headache (side) Yes (starting with the 2nd episode; bilateral or left sided) Yes (starting with her 5th episode; left-sided and eye pain) Yes (starting with the 2nd episode at the age of 6 yr and 8 mo after a fall backwards – no apparent headache at 1st episode) Yes (behind the left eye, described as sharp and fluctuating in intensity) Yes (L; supraorbital) Yes Yes
Associated symptoms No Yes No Yes No - -
Photophobia - - - Yes - - -
Phonophobia - - - Yes - - -
Nausea - - - Yes - - -
Vomiting - Yes - Yes (sometimes) - - -
Irritability - Yes - - - - -
Other findings

Signs of varicella infection at 2nd episode

Dizziness at 4th episode

Drowsiness - Attacks of screaming - - -
Ocular symptoms/signs Yes Yes Yes Yes Yes - -
Diplopia NS NS Yes NS Yes - -
Ophthalmoplegia Yes (not always present) Yes Yes Yes Yes - -
Palpebral ptosis Yes Yes Yes Yes Yes - -
Pupillary dilation Yes (poorly reactive pupil to light) Yes Yes (poorly reactive to light) Yes (reactive to light with progression to unresponsive pupil) Yes (sluggish response to light) No Yes
MRI findings in the acute phase MRI perfomerd 12 days later 2nd episode onset (ptosis partially resolved) Not performed Yes – At second episode (not performed at the 1st episode) Yes Yes – performed after 2 weeks of onset (several foci of white matter hyperintensity measuring 3 mm or less identified in the dorsal periventricular region) Yes Yes
Nerve thickening Yes (from the brainstem through the prepontin cistern to the carvernous sinus) - Yes No No Yes Yes
Post-contrast enhancement Yes - Yes Yes—at the point of exit of the nerve from the midbrain, continuing along the line of the nerve No Yes Yes
Altered CSF if lumbar puncture performed No (2nd episode) No No NS - - -
Headache duration 3–4 days NS NS NS NS - -
Ophthalmoplegia duration NS NS NS NS NS - -
Interval between headache onset and ophthalmoplegia 3–4 days 1 day 4 days (second episode) NS – 3–4 days between headache and palpebral ptosis NS - -
Time to resolution of Symptoms/Signs 6–8 weeks 6 mo (1st episode) Within 2 weeks (first episode) From few days (2–11) to 2 months NS - -
Therapy in the acute phase Prednisone (2 mg/kg/day) for about 10 days with apparent response NS NS NS - - -
Follow-up Yes ( refered migraine attacks without ophthalmoplegia) Yes (permanent partial III CN palsy) - Yes (with apparent decreased number of episodes) NS - -
Prophylactic therapy -

Propranolol

Metoclopramide

Diazepam

Acetaminophen

- Cafergot; Aspirin; Amitriptyline; Pizotifen; Flunarizine ( 10 mg/day with apparent response) NS - -
Control MRI Performed after 3 months of the 3rd episode onset (persistent enlargement of III CN but to a lesser degree) MRIs at 14, 15, 16-years-of-age showing persistent enlargement (from the brainstem through the prepontin cistern to the carvernous sinus) NS

A repeat MRI scan showed enhancement of the oculomotor nerve still present but less intense;

unenhanced MRIs of the brain at the ages of 12 and 14 years were normal

- - -
Number of acute episodes NS ( about four episodes) NS NS NS – About 38 episodes - - -
Interval between episodes Range 15 mo -3 yr 6–9 mo NS NS - - -
Comorbidity Migraine - Migraine without aura - Migraine - -
Family history of migraine No No Yes (on the maternal side) Yes (on the maternal side) No Yes No